Transforming brain cancer therapeutics: unlocking the power of blood-brain barrier-targeting strategies for superior treatment outcomes and precision medicine

Sep 24, 2024Neurosurgical review

Improving brain cancer treatment by targeting the blood-brain barrier for better outcomes and personalized care

AI simplified

mRNA Technology on OpenScience ↗PubMed ↗DOI ↗

Abstract

Recent advancements in therapies targeting the Blood-Brain Barrier (BBB) offer new strategies for treating brain tumors.

Convection-Enhanced Delivery (CED) and RNA-based therapeutics may enhance drug delivery directly to tumor sites while reducing systemic toxicity.
Theranostic nanoparticles and CRISPR-Cas9 gene editing could provide real-time monitoring and precision-targeted therapy for brain cancer.
Techniques like magnetic nanoparticles, intranasal drug administration, and focused ultrasound with microbubbles are being refined to improve drug penetration across the BBB.
Peptide-based delivery systems and small molecules that mimic natural transport pathways may accelerate the discovery of more effective brain cancer therapies.
Combination therapies that integrate BBB-penetrant drugs with conventional treatments are being explored to potentially enhance treatment efficacy.

AI simplified

The treatment of brain tumors is significantly hindered by the Blood-Brain Barrier (BBB), a selective barrier that restricts the passage of therapeutic agents to the brain. Recent advancements in BBB-targeting therapies offer promising strategies to overcome this challenge, providing new avenues for the effective treatment of brain cancer. This article reviews innovative approaches, including Convection-Enhanced Delivery (CED) and RNA-based therapeutics, which enhance drug delivery directly to tumor sites, bypassing the BBB and reducing systemic toxicity. Additionally, the use of theranostic nanoparticles and CRISPR-Cas9 gene editing presents novel opportunities for real-time monitoring and precision-targeted therapy, respectively. Techniques such as magnetic nanoparticles, intranasal drug administration, and focused ultrasound with microbubbles are also being refined to improve drug penetration across the BBB. Furthermore, peptide-based delivery systems and small molecules designed to mimic endogenous transport pathways are accelerating the discovery of more effective therapies. The exploration of combination therapies that synergize BBB-penetrant drugs with conventional chemotherapeutic agents or immunotherapies holds the potential to enhance treatment efficacy and patient outcomes. Continued research and interdisciplinary collaboration are essential to develop predictive models, personalized treatment strategies, and alternative delivery methods that ensure the long-term safety and effectiveness of these novel therapies. Advancements in BBB-targeting therapeutics are poised to transform the landscape of brain cancer treatment, offering renewed hope for improved survival rates and quality of life for patients.

Full Text

Full text is available at the source.

View full text (PDF) ↗View full text (HTML) ↗

Transforming brain cancer therapeutics: unlocking the power of blood-brain barrier-targeting strategies for superior treatment outcomes and precision medicine

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the mrna technology brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the mrna technology brief